Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio
- PMID: 432544
- DOI: 10.3109/00365527909179871
Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio
Abstract
Enteroglucagon concentration in peripheral blood was determined before and after a test meal in 24 morbidly obese patients. Eighteen had jejunoileal bypass, 6 with a 3:1 and 12 with a 1:3 jejunoileal ratio of the functioning segment, and 6 were unoperated. All three groups exhibited an increment of enteroglucagon concentration after the meal. Both the fasting values and the postprandial integrated increments were higher in operated patients than in unoperated patients and higher after 1:3 bypass than after 3:1 bypass. The findings agree with the hypothesis that enteroglucagon secretion is stimulated by exposure of the lower bowel to upper-bowel content, and that the effect of enteroglucagon is, as seen after bypass operation, stimulation of growth and reduction of motility of the intestine.
Similar articles
-
Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.Digestion. 1983;26(3):137-45. doi: 10.1159/000198880. Digestion. 1983. PMID: 6343164 Clinical Trial.
-
Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation.Int J Obes. 1986;10(1):37-42. Int J Obes. 1986. PMID: 3710688
-
[Behavior of plasma enteroglucagon and neurotensin in obese patients subjected to biliopancreatic bypass].Boll Soc Ital Biol Sper. 1980 Oct 15;56(19):1915-21. Boll Soc Ital Biol Sper. 1980. PMID: 7459102 Italian.
-
Elevated plasma enteroglucagon alone fails to alter distal colonic carcinogenesis in rats.Gastroenterology. 1987 Mar;92(3):617-24. doi: 10.1016/0016-5085(87)90009-6. Gastroenterology. 1987. PMID: 3817385
-
Fasting and meal-stimulated plasma levels of neurotensin in obese patients after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.Scand J Gastroenterol. 1987 Jan;22(1):69-74. doi: 10.3109/00365528708991859. Scand J Gastroenterol. 1987. PMID: 3563413 Clinical Trial.
Cited by
-
Enhancing bowel adaptation in short bowel syndrome.Curr Gastroenterol Rep. 2002 Aug;4(4):338-47. doi: 10.1007/s11894-002-0085-0. Curr Gastroenterol Rep. 2002. PMID: 12149180 Review.
-
Influence of somatostatin and bombesin on plasma enteroglucagon and cell proliferation after intestinal resection in the rat.Gut. 1985 Jan;26(1):89-94. doi: 10.1136/gut.26.1.89. Gut. 1985. PMID: 2856910 Free PMC article.
-
Unraveling oxyntomodulin, GLP1's enigmatic brother.J Endocrinol. 2012 Dec;215(3):335-46. doi: 10.1530/JOE-12-0368. Epub 2012 Sep 27. J Endocrinol. 2012. PMID: 23019069 Free PMC article. Review.
-
Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity.Front Endocrinol (Lausanne). 2021 Sep 8;12:735019. doi: 10.3389/fendo.2021.735019. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34566894 Free PMC article. Review.
-
Gut adaptation and the glucagon-like peptides.Gut. 2002 Mar;50(3):428-35. doi: 10.1136/gut.50.3.428. Gut. 2002. PMID: 11839727 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources